Health Care (CNBC)
Eli Lilly to build $4.5 billion research and manufacturing center to propel drug pipeline
Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer's disease, ALS and other brain diseases, CEO David Ricks said.
22 hours 2 minutes ago
Checkout newsRecursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
Recursion said it was able to use its AI-enabled drug discovery platform to identify a novel target and move all the way to gaining IND approval in less than 18 months.
1 day 1 hour ago
Checkout newsHealthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care cybersecurity following major attacks.
1 day 19 hours ago
Checkout newsCVS is working with advisors on strategic review, sources say
CVS Health's board has engaged advisors to conduct a strategic review of its business, according to people familiar with the matter.
2 days ago
Checkout newsMajor CVS shareholder plans activist push, will meet with management, sources say
Glenview Capital is expected to meet with CVS management on Monday to discuss its plans for value creation at the struggling business.
2 days 17 hours ago
Checkout newsGE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare's quiet outperformance is becoming harder to tune out.
2 days 18 hours ago
Checkout newsHarris leads with Latino voters, but the economy narrows the margin for Dems: Survey
10 things to watch in the stock market Friday including a bullish call on Best Buy
Wall Street is on track for weekly gains, led by the tech-heavy Nasdaq Composite.
6 days ago
Checkout newsFDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
6 days 15 hours ago
Checkout newsNovo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.
1 week ago
Checkout news'Stop ripping us off': Senate grills Novo Nordisk CEO on weight loss drug pricing
Sen. Bernie Sanders argues that Novo Nordisk charges Americans substantially higher prices for its drugs than it does for patients in other countries.
1 week 1 day ago
Checkout newsHealthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an antitrust suit against Epic Systems.
1 week 1 day ago
Checkout newsBrett Favre tells Congress he's been diagnosed with Parkinson's
The embattled former Green Bay quarterback made the surprising disclosure as he testified about possible misuse of taxpayer money, NBC News reports.
1 week 1 day ago
Checkout news'Economy class syndrome' is a medical issue that can happen on flights — no matter where you sit
Deep vein thrombosis can be a serious health issue that strikes at any time. But medium-to long-haul flights increase the risk of developing it.
1 week 2 days ago
Checkout newsFTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts.
1 week 4 days ago
Checkout newsWhy Eli Lilly and Palo Alto Networks are both up on news from their competitors
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
1 week 5 days ago
Checkout newsPesky medical bill? Many people don't take a key step to manage that debt, study finds
Many people who don't question potential errors on medical bills think doing so won't get results. Evidence suggests otherwise.
1 week 5 days ago
Checkout newsNovartis not joining the 'frenzy' of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
2 weeks 1 day ago
Checkout news23andMe CEO Anne Wojcicki 'surprised and disappointed' by board resignations: Read the memo
In a memo to employees on Tuesday, 23andMe CEO Anne Wojcicki said the company will search for new directors.
2 weeks 1 day ago
Checkout newsHealthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
2 weeks 1 day ago
Checkout newsIn 51 U.S. states are published
5242
Companies
1654
Counties
2831
Cities
The 5 newest Companies
9545 Kenwood Rd UNIT 204, Blue Ash, OH 45242
655 Cottage St NE, Salem, OR 97301
1317 Grandview Ave, Ceres, CA 95307
472 Main St, Hopkinton, RI 02804
533 S Main St, Chambersburg, PA 17201
Other Companies
30 W Gude Dr, Rockville, MD 20850
200 W Hale Ave # 300, Osceola, AR 72370
1933 Dr Martin Luther King Way, Sarasota, FL 34234
496 Plainville Ave, Unionville, CT 06085
735 E Oldtown Rd, Cumberland, MD 21502